Dr. Gong is the Chief of Critical Care Medicine, Chief of Pulmonary Medicine, and Director of Critical Care Research at Montefiore Medical Center and Professor in Medicine and in Epidemiology and Population Health at Albert Einstein College of Medicine. After receiving an engineering degree at the University of Pennsylvania, Dr. Gong went on to earn a medical degree at the Yale University School of Medicine. She then completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She also studied at the Harvard School of Public Health, receiving her Master’s degree in Clinical Epidemiology. Prior to coming to Albert Einstein College of Medicine and Montefiore Medical Center, she was Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep Medicine at the Mount Sinai School of Medicine. She joined the Einstein/Montefiore faculty in July 2009.
Dr. Gong is recognized nationally and internationally for her expertise in critical care delivery and management of acute respiratory failure and acute respiratory distress syndrome (ARDS). She has spent her career on improving outcomes in patients along the entire continuum of critical illness from its development to its progression and recovery with an overall focus on the prediction and prevention of acute organ failure and their complications. Nationally, she is a well-respected clinical researcher and trialist in acute injury and critical illness. Continuously funded by the NIH for over 20 years for her work, her research ranges from COVID-19 and ARDS to prevention of delirium, treatment of severe influenza, big data and predictive analytics in risk prediction, and effective clinical decision support systems. Her research has been published in the New England Journal of Medicine and JAMA. She has also been funded by the AHRQ on clinical decision making in ARDS and by the NHLBI for the Montefiore-Sinai Clinical Center for the PETAL Clinical Trials Network focused on the prevention and early treatment of ARDS.
A model clinician-researcher, her scientific projects influence her clinical care, and her patients motivates her research. So it is not surprising that some of her proudest achievements have occurred within her clinical work to improve outcomes for patients within Montefiore. This has included process improvement projects such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit that has reduced duration of mechanical ventilation, length of stay, hospital costs and ICU complications. She has also worked on the incorporation of artificial intelligence to help identify patients at increased risk of poor outcomes at Montefiore and evaluation of clinical decision support systems. She has co-authored the Surviving Sepsis Guidelines on management of patients with COVID-19, published in Intensive Care Medicine.
Dr. Gong is a well-regarded leader in the field of pulmonary and critical care medicine. She is a graduate of the prestigious Executive Leadership in Academic Medicine Fellowship and was the former or current chair of the Critical Care Planning Committee and the Critical Care Assembly for the American Thoracic Society. She is also on the Discovery Oversight Committee that helps plan the direction and agenda for the clinical trials initiative of the Society of Critical Care Medicine. Dr. Gong was awarded the Gotham Icon Award for Champions and Change Makers of New York City by the Museum of the City of New York in 2020. Given her expertise, she has been named to multiple panels to develop clinical practice guidelines, including the American College of Chest Physicians and the American Thoracic Society clinical practice guidelines for liberation from mechanical ventilation and the Surviving Sepsis Campaign guidelines for management of severe COVID-19 in 2020. In these leadership positions, she has had the fortune and privilege to mentor residents, fellows and junior investigators both within and beyond Montefiore into productive, academic careers in medicine.